Aisling Capital
New York, US · Seed → Growth
Their stated focus (public profile)
Aisling Capital is a healthcare-focused investment firm that invests in products, technologies, and global businesses that advance health, with a focus on life sciences including biopharmaceuticals, medical devices, diagnostics, and healthcare services. The firm targets companies developing innovative healthcare products addressing unmet medical needs, investing across both private and public companies using a range of structures including seed/venture financings, small-cap public equities, structured debt, royalty deals, and leveraged buyouts. With over $1.8 billion in committed capital raised since 2000 across five funds, Aisling takes an active, hands-on approach working closely with portfolio company management teams.
Stages: Seed → Growth
Sectors: Life sciences, Consumer, Medtech, Services, Healthtech
On file: 40 companies on record
Website: aislingcapital.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.